Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a hereditary renal phosphate-wasting disorder characterized by hypophosphatemia and hypercalciuria associated with rickets and/or osteomalacia.
Features include always present findings: Elevated circulating alkaline phosphatase concentration, Renal phosphate wasting, Hypophosphatemic rickets, and Hypercalciuria and others; and very common findings: High serum calcitriol. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 6 | Femoral bowing, Recurrent fractures, Hypophosphatemic rickets |
SLC34A3 function has not been fully characterized.
Hereditary hypophosphatemic rickets with hypercalciuria is associated with mutations in the SLC34A3 gene on chromosome 9.
Genetic testing for SLC34A3 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 5 always present features, 1 very common feature, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
11 publications have been identified in PubMed for hereditary hypophosphatemic rickets with hypercalciuria. Research spans Case Report / Case Series (45%), Other (18%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 45% |
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 2:50 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles |
3 |
Low muscle tone (hypotonia), Renal phosphate wasting, Muscle weakness |
Kidneys and urinary system | 3 | Renal phosphate wasting, Calcium nephrolithiasis, Renal tubular dysfunction |
Lab test results | 2 | Elevated circulating alkaline phosphatase concentration, Decreased circulating parathyroid hormone level |
Growth and development | 2 | Failure to thrive, Growth delay |
Brain and nerves | 1 | Difficulty walking (gait disturbance) |
Other research |
2 |
18% |
Research summaries | 2 | 18% |
Laboratory research | 1 | 9% |
Disease patterns and progression | 1 | 9% |
Olarewaju BA (2026). [PMID: 41849633](https://pubmed.ncbi.nlm.nih.gov/41849633/). *Kidney Blood Press Res*. [Case Report / Case Series]
Bruneau H (2026). [PMID: 42138629](https://pubmed.ncbi.nlm.nih.gov/42138629/). *Arch Endocrinol Metab*. [Review / Meta-Analysis]
Sharova M (2025). [PMID: 40694099](https://pubmed.ncbi.nlm.nih.gov/40694099/). *Pediatr Nephrol*. [Case Report / Case Series]
Sun Y (2025). [PMID: 39634134](https://pubmed.ncbi.nlm.nih.gov/39634134/). *Genes Dis*. [Basic Science / Preclinical]
Mura-Escorche G (2025). [PMID: 40943461](https://pubmed.ncbi.nlm.nih.gov/40943461/). *Int J Mol Sci*. [Case Report / Case Series]
Filler G (2025). [PMID: 41035763](https://pubmed.ncbi.nlm.nih.gov/41035763/). *Bone Rep*. [Epidemiology / Natural History]
Wettasinghe CA (2025). [PMID: 40820604](https://pubmed.ncbi.nlm.nih.gov/40820604/). *J Clin Res Pediatr Endocrinol*. [Case Report / Case Series]
Valadares LP (2025). [PMID: 37680384](https://pubmed.ncbi.nlm.nih.gov/37680384/). *J Clin Res Pediatr Endocrinol*. [Case Report / Case Series]
Zhu Z (2024). [PMID: 38906648](https://pubmed.ncbi.nlm.nih.gov/38906648/). *Kidney Int*. [Other]
Zhu Z (2024). [PMID: 38364990](https://pubmed.ncbi.nlm.nih.gov/38364990/). *Kidney Int*. [Review / Meta-Analysis]